Amal M El-Naggar

13PUBLICATIONS
68CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer cell biologyMajor global burdens of diseaseCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 25, 2026
Beyond Hydrogen Sulfide and Cysteine Metabolism: Reframing Cystathionine γ-Lyase as a Potential Translational Regulator of Hypoxia-Inducible Factor-1α in Clear Cell Ovarian Carcinoma.

|May 29, 2025
Author Correction: Class I HDAC inhibitors enhance YB-1 acetylation and oxidative stress to block sarcoma metastasis.

Amal M El-Naggar, Syam Prakash Somasekharan, Yemin Wang

|May 15, 2025
Cystathionine gamma-lyase-mediated hypoxia inducible factor 1-alpha expression drives clear cell ovarian cancer progression.

Amal M El-Naggar, Yuqin Li, Busra Turgu

|Oct 09, 2023
Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing Sarcoma.

Brian Mooney, Gian Luca Negri, Taras Shyp

|Jul 26, 2023
Biallelic Dicer1 Mutations in the Gynecologic Tract of Mice Drive Lineage-Specific Development of DICER1 Syndrome-Associated Cancer.

Yemin Wang, Shary Yuting Chen, Monica Ta

|Jul 23, 2021
De novo and cell line models of human mammary cell transformation reveal an essential role for Yb-1 in multiple stages of human breast cancer.

Sylvain Lefort, Amal El-Naggar, Susanna Tan

Pageof 3

Frequent Collaborators

5 joint publications

Gian Luca Negri

4 joint publications

Gregg B Morin

3 joint publications

David G Huntsman

3 joint publications

Poul H Sorensen